The Japan Glaucoma Society guidelines for glaucoma 5th edition
- PMID: 36780040
- DOI: 10.1007/s10384-022-00970-9
The Japan Glaucoma Society guidelines for glaucoma 5th edition
Abstract
We are pleased to bring you the 5th edition of the Glaucoma Clinical Practice Guidelines. Clinical practice guidelines are based on evidence (scientific grounds). It is a document that presents the treatment that is the most appropriate for the patient. "Glaucoma Clinical Guidelines" was first published in 2003. This was the first guideline for glaucoma treatment in Japan. The principle of glaucoma treatment is to lower intraocular pressure. Means for lowering intraocular pressure includes drugs, lasers, and surgery; Glaucoma is a disease that should be considered as a complex syndrome rather than a single condition. Therefore, the actual medical treatment is not as simple as one word. This time we set the Clinical Questionnaire with a focus on glaucoma treatment. We hope that you will take advantage of the 5th edition.
Keywords: 5th edition; Glaucoma; Guideline; Japan Glaucoma Society.
© 2023. Japan Glaucoma Society.
Similar articles
-
Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.Health Technol Assess. 2019 Jun;23(31):1-102. doi: 10.3310/hta23310. Health Technol Assess. 2019. PMID: 31264958 Free PMC article. Clinical Trial.
-
A deep dive into the latest European Glaucoma Society and Asia-Pacific Glaucoma Society guidelines and their relevance to India.Indian J Ophthalmol. 2022 Jan;70(1):24-35. doi: 10.4103/ijo.IJO_1762_21. Indian J Ophthalmol. 2022. PMID: 34937204 Free PMC article. Review.
-
European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.Br J Ophthalmol. 2017 Jun;101(6):130-195. doi: 10.1136/bjophthalmol-2016-EGSguideline.003. Br J Ophthalmol. 2017. PMID: 28559477 Free PMC article. No abstract available.
-
Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment.Adv Ther. 2018 Nov;35(11):1775-1804. doi: 10.1007/s12325-018-0812-z. Epub 2018 Oct 20. Adv Ther. 2018. PMID: 30341506 Free PMC article. Review.
-
[Examinations by ocular pressure tonometry].Klin Monbl Augenheilkd. 1990 Sep;197(3):225-30. doi: 10.1055/s-2008-1046274. Klin Monbl Augenheilkd. 1990. PMID: 2255164 German.
Cited by
-
Glaucoma Ex-PRESS Implantation Surgery: Is There a Difference in Efficacy and Safety between Inpatient and Outpatient Management?JMA J. 2024 Jul 16;7(3):431-434. doi: 10.31662/jmaj.2023-0216. Epub 2024 Jun 3. JMA J. 2024. PMID: 39114630 Free PMC article. No abstract available.
-
The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients.J Clin Med. 2024 Jul 16;13(14):4158. doi: 10.3390/jcm13144158. J Clin Med. 2024. PMID: 39064198 Free PMC article.
-
Glaucoma progression due to refraining examination amid the pandemic of COVID-19.Int Ophthalmol. 2024 Apr 25;44(1):196. doi: 10.1007/s10792-024-03151-4. Int Ophthalmol. 2024. PMID: 38662242
-
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2579-2591. doi: 10.1007/s00417-024-06388-y. Epub 2024 Mar 2. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38430227 Free PMC article. Clinical Trial.
-
Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil.Clin Ophthalmol. 2024 Feb 7;18:423-430. doi: 10.2147/OPTH.S446962. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38343903 Free PMC article.
References
-
- World Glaucoma Association. Childhood glaucoma. In: Weinreb RN, Grajewski AL, Papadopoulos M, Grigg J, Freedman S, editors. The 9th Consensus report of the world glaucoma association. Amsterdam: Kugler Publications; 2013. p. 1–270.
-
- Suzuki Y, Iwase A, Araie M, Yamamoto T, Abe H, Shirato S, et al. Risk factors for open-angle glaucoma in a Japanese population. Tajimi Study Ophthalmol. 2006;113:1613–7. - DOI
-
- AGIS investigators: The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134:499–512.
-
- Yamamoto T, Iwase A, Araie M, Suzuki Y, Abe H, Shirato S, et al: Tajimi Study Group, Japan Glaucoma Society. The Tajimi Study report 2: prevalence of primary angle-closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112:1661–9.
Secondary references
-
- SR1. European Glaucoma Society. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition—Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol. 2017;101:130–95.
-
- SR2. Terminology and guidelines for glaucoma 5th edition. European Glaucoma Society, 2020.
-
- SR3. Primary angle-closure disease preferred practice pattern. American Academy of Ophthalmology, 2020.
-
- SR4. Asia Pacific Glaucoma Guidelines. Asian Pacific Glaucoma Society, Kugler Publications, 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
